BACKGROUND: Bariatric surgery allows stable body weight reduction in morbidly obese patients. In presurgical evaluation, obesity-related co-morbidities must be considered, and a multidisciplinary approach is recommended. Precise guidelines concerning the endocrinological evaluation to be performed before surgery are not available. The aim of this study was to evaluate the prevalence of common endocrine diseases in a series of obese patients scheduled for bariatric surgery. METHODS: We examined 783 consecutive obese subjects (174 males and 609 females) aged 18-65 years, who turned to the obesity centre of our department from January 2004 to December 2007 for evaluation before bariatric surgery. Thyroid, parathyroid, adrenal and pituitary function was evaluated by measurement of serum hormones. Specific imaging or supplementary diagnostic tests were performed when indicated. RESULTS: The overall prevalence of endocrine diseases, not including type 2 diabetes mellitus, was 47.4%. The prevalence of primary hypothyroidism was 18.1%; pituitary disease was observed in 1.9%, Cushing syndrome in 0.8%, while other diseases were found in less than 1% of subjects. Remarkably, the prevalence of newly diagnosed endocrine disorders was 16.3%. CONCLUSIONS: A careful endocrinological evaluation of obese subjects scheduled for bariatric surgery may reveal undiagnosed dysfunctions that require specific therapy and/or contraindicate the surgical treatment in a substantial proportion of patients. These results may help to define the extent of the endocrinological screening to be performed in obese patients undergoing bariatric surgery.
BACKGROUND: Bariatric surgery allows stable body weight reduction in morbidly obesepatients. In presurgical evaluation, obesity-related co-morbidities must be considered, and a multidisciplinary approach is recommended. Precise guidelines concerning the endocrinological evaluation to be performed before surgery are not available. The aim of this study was to evaluate the prevalence of common endocrine diseases in a series of obesepatients scheduled for bariatric surgery. METHODS: We examined 783 consecutive obese subjects (174 males and 609 females) aged 18-65 years, who turned to the obesity centre of our department from January 2004 to December 2007 for evaluation before bariatric surgery. Thyroid, parathyroid, adrenal and pituitary function was evaluated by measurement of serum hormones. Specific imaging or supplementary diagnostic tests were performed when indicated. RESULTS: The overall prevalence of endocrine diseases, not including type 2 diabetes mellitus, was 47.4%. The prevalence of primary hypothyroidism was 18.1%; pituitary disease was observed in 1.9%, Cushing syndrome in 0.8%, while other diseases were found in less than 1% of subjects. Remarkably, the prevalence of newly diagnosed endocrine disorders was 16.3%. CONCLUSIONS: A careful endocrinological evaluation of obese subjects scheduled for bariatric surgery may reveal undiagnosed dysfunctions that require specific therapy and/or contraindicate the surgical treatment in a substantial proportion of patients. These results may help to define the extent of the endocrinological screening to be performed in obesepatients undergoing bariatric surgery.
Authors: Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt Journal: Thyroid Date: 2003-01 Impact factor: 6.568
Authors: T Rago; W Bencivelli; M Scutari; C Di Cosmo; C Rizzo; P Berti; P Miccoli; A Pinchera; P Vitti Journal: J Endocrinol Invest Date: 2006-05 Impact factor: 4.256
Authors: John J Kelly; Scott Shikora; Daniel B Jones; Matthew H Hutter; Malcolm K Robinson; John Romanelli; Frederick Buckley; Andrew Lederman; George L Blackburn; David Lautz Journal: Obesity (Silver Spring) Date: 2009-02-19 Impact factor: 5.002
Authors: F Aghini-Lombardi; L Antonangeli; E Martino; P Vitti; D Maccherini; F Leoli; T Rago; L Grasso; R Valeriano; A Balestrieri; A Pinchera Journal: J Clin Endocrinol Metab Date: 1999-02 Impact factor: 5.958
Authors: Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou Journal: Thyroid Date: 2006-01 Impact factor: 6.568
Authors: Roman Schumann; Stephanie B Jones; Bronwyn Cooper; Scott D Kelley; Mark Vanden Bosch; Vilma E Ortiz; Kathleen A Connor; Michael D Kaufman; Alan M Harvey; Daniel B Carr Journal: Obesity (Silver Spring) Date: 2009-02-19 Impact factor: 5.002
Authors: Paul Poirier; Martin A Alpert; Lee A Fleisher; Paul D Thompson; Harvey J Sugerman; Lora E Burke; Picard Marceau; Barry A Franklin Journal: Circulation Date: 2009-06-15 Impact factor: 29.690
Authors: Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora Journal: Obes Surg Date: 2016-08 Impact factor: 4.129
Authors: Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer Journal: Obesity (Silver Spring) Date: 2013-03 Impact factor: 5.002
Authors: Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer Journal: Endocr Pract Date: 2013 Mar-Apr Impact factor: 3.443
Authors: Jorge Pedro; Filipe Cunha; Pedro Souteiro; João Sérgio Neves; Vanessa Guerreiro; Daniela Magalhães; Rita Bettencourt-Silva; Sofia Castro Oliveira; Maria Manuel Costa; Joana Queirós; Paula Freitas; Ana Varela; Davide Carvalho Journal: Obes Surg Date: 2018-11 Impact factor: 4.129